Treatment of Heelpain by Agnikarma and Vidhya Agnikarma

Open Labeled Randomized controlled Trial TO Compare The Effect Of Agnikarma And Viddha-Agnikarma In Vatakantak (Plantar Fasciitis)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049952

Enrollment

Registered

2023-02-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M722- Plantar fascial fibromatosis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Clinically diagnosed Patients of Vatakantaka (plantar fasciitis) 2. Age group more than 18 years. 3. Selection will be irrespective of gender, religion and socio-economic status

Exclusion criteria

Exclusion criteria: 1. Uncontrolled systemic diseases like diabetes mellitus, hypertension. 2. Fracture of calcaneum. 3. Other pathologies like osteomyelitis of calcaneum. 4. Immuno-compromised Patients.

Design outcomes

Primary

Measure	Time frame
To study the effect of Viddha-Agnikarma in Vatakantaka in pain management and compare its effect with Agnikarma.(Plantar Fasciitis)Timepoint: follow up on 4th , 7th day	—

Secondary

Measure	Time frame
To study other adverse effect of Viddha-AgnikarmaTimepoint: follow up on 4th, 7th day	—

Countries

India

Contacts

Public ContactDr Anjali Subhashrao Suryawanshi

Shri Ayurved Mahavidyalya, Nagpur

drsandesh1128@gmail.com9987014379

Outcome results